[Answered] One reason why there is so little epidemiologic data for personality disorders is that they cannot ...

This topic contains a solution. Click here to go to the answer

Author Question: One reason why there is so little epidemiologic data for personality disorders is that they cannot ... (Read 61 times)

shenderson6

Hero Member
Posts: 573

on: Jun 22, 2018

One reason why there is so little epidemiologic data for personality disorders is that they cannot be reliably diagnosed after only one session or interview.

Indicate whether the statement is true or false

Question 2

Busy physicians have access to very brief screening devices to assess the presence of psychological problems.

Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

firehawk60

Sr. Member
Posts: 315

Reply #1 on: Jun 22, 2018

Answer to Question 1

TRUE

Answer to Question 2

TRUE

shenderson6

Member
Posts: 573

Reply 2 on: Jun 22, 2018

TYSM

tuate

Member
Posts: 332

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Signs of depression include feeling sad most of the time for 2 weeks or longer; loss of interest in things normally enjoyed; lack of energy; sleep and appetite disturbances; weight changes; feelings of hopelessness, helplessness, or worthlessness; an inability to make decisions; and thoughts of death and suicide.